Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series
Daniel J. Lewis, Yevgeniya A. Byekova, Drew A. Emge, et al.
Journal of Dermatological Treatment (2017) Vol. 28, Iss. 6, pp. 567-569
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 66
Skin Directed Therapy in Cutaneous T-Cell Lymphoma
Erica S. Tarabadkar, Michi M. Shinohara
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 52
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020
Małgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 10, pp. 733-745
Open Access | Times Cited: 42
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches
David M. Weiner, Joseph S. Durgin, Maria Wysocka, et al.
Journal of the American Academy of Dermatology (2020) Vol. 84, Iss. 3, pp. 597-604
Open Access | Times Cited: 42
Advances in classification and treatment of primary cutaneous lymphomas
Hong Zheng, Lihua Qiu, Chang Liu, et al.
Annals of Hematology (2025)
Open Access
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment
Natalia Rendón‐Serna, Luis Alfonso Correa Londoño, Margarita María Velásquez‐Lopera, et al.
International Journal of Dermatology (2021) Vol. 60, Iss. 12, pp. 1462-1480
Closed Access | Times Cited: 16
Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario
José Antônio Sanches, Jade Cury‐Martins, Rodrigo Martins Abreu, et al.
Anais Brasileiros de Dermatologia (2021) Vol. 96, Iss. 4, pp. 458-471
Open Access | Times Cited: 14
Mycosis Fungoides and Sézary Syndrome
Walter Hanel, Catherine Chung, John Reneau
Holland‐Frei Cancer Medicine (2022), pp. 1-7
Closed Access | Times Cited: 10
Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
Taku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 200-200
Open Access | Times Cited: 13
Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma
Paula Di Sciullo, Florencia Menay, Federico Cocozza, et al.
Clinical Immunology (2019) Vol. 203, pp. 154-161
Open Access | Times Cited: 15
The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies
Maria Leśniak, Justyna Lipniarska, Patrycja Majka, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 277-277
Open Access | Times Cited: 4
Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature
Doaa Shalabi, Nish Vadalia, Neda Nikbakht
Dermatology and Therapy (2019) Vol. 9, Iss. 4, pp. 807-814
Open Access | Times Cited: 10
Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy With Intralesional Injections of 5-Fluorouracil and Topical Imiquimod
Michael Lindberg
Cutis (2023) Vol. 111, Iss. 1
Open Access | Times Cited: 2
Les lymphomes cutanés T
M. D’Incan
Bulletin du Cancer (2024)
Closed Access
Immunobiology and treatment of cutaneous T-cell lymphoma
Rishi R. Goel, Alain H. Rook
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 985-996
Closed Access
Mycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatment
Gautam Kumar Singh, Pankaj Das, Sarita Srivastava, et al.
Indian Journal of Dermatology Venereology and Leprology (2024), pp. 1-8
Open Access
Management of relapsed cutaneousT‐Celllymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case
David M. Weiner, Daniel J. Lewis, Natalie Spaccarelli, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 7
Open Access | Times Cited: 2
Antiviral Drugs
Sreekumar Othumpangat, John D. Noti
Side effects of drugs annual (2018), pp. 345-361
Closed Access | Times Cited: 2
Primary cutaneous lymphomas in dermatological practice
Jiří Ettler, Jindřich Polívka, Petr Arenberger
Onkologie (2018) Vol. 12, Iss. 3, pp. 111-116
Open Access | Times Cited: 1
New developments in skin-directed treatments of cutaneous T-cell lymphoma
Iris Amitay‐Laish, Emmilia Hodak
La Presse Médicale (2022) Vol. 51, Iss. 1, pp. 104125-104125
Closed Access | Times Cited: 1
Current therapies for mycosis fungoides
Н. Н. Потекаев, V.S. Morozova, Е. А. Baryakh, et al.
Russian Journal of Clinical Dermatology and Venereology (2022) Vol. 21, Iss. 4, pp. 538-538
Closed Access | Times Cited: 1
Potential uses of Topical Resiquimod for Mycosis Fungoides Tumor Stage
Alberto Boretti
Current Organocatalysis (2023) Vol. 11, Iss. 1, pp. 2-6
Closed Access
Imiquimod tópico para tratar la micosis fungoide en fase tumoral con pocos nódulos o nódulos aislados
Alberto Boretti
Piel (2023) Vol. 39, Iss. 5, pp. 296-299
Closed Access
Imiquimod

Reactions Weekly (2018) Vol. 1686, Iss. 1, pp. 196-196
Closed Access
Skin directed treatment of cutaneous T-cell lymphomas, case report
Melánia Pozsgai, Rolland Gyulai, Csaba Gyömörei, et al.
Bőrgyógyászati és Venerológiai Szemle (2020) Vol. 96, Iss. 5, pp. 212-218
Open Access
Page 1 - Next Page

Scroll to top